Testing a Measurement Feedback App to Improve Data Quality, Supervision & Outcomes in Behavioral Health
University of Pennsylvania · with National Institute of Mental Health (NIMH) · NCT07042347
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 200
- US sites recruiting
- 1
- Study start
- April 8, 2026
- Record last updated
- May 8, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to test whether a smartphone-based data collection and feedback application ("Footsteps") improves the quality of behavioral data collected by one-to-one aides and leads to better youth mental health outcomes in school-aged youth (ages 4-17) who receive one-to-one support in schools.
The main questions it aims to answer are
- Does the Footsteps app improve aides' data collection quality (i.e., consistency, timeliness, and completeness)?
- Does Footsteps use lead to improved youth behavioral health outcomes (e.g., SDQ, YTP scores)?
- Does Footsteps improve communication and supervision processes between aides and clinical supervisors?
Researchers will compare aides using Footsteps to those using a "data collection only" control app to see if Footsteps leads to higher quality data collection, enhanced supervisory communication, and better youth outcomes.
Participants will
- Use either Footsteps or a control app to record de-identified data on one client's behaviors and skills over 12 weeks
- Complete biweekly online surveys about data collection experiences, youth progress, and aide-supervisor communication
- Participate in a virtual intake and post-trial meeting
- (For a subset) Participate in a 30-45 minute qualitative interview about their experience using the app
Being studied: Behavioral economics strategies; Electronic platform
Conditions: Autism; Challenging Behavior; ADHD; Oppositional Defiant Disorder
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Aides must be working with at least one client in school who meets the following criteria: 1) between 3-17 years, 2) has a diagnosis associated with a challenging behavior (e.g., autism spectrum disorder, attention deficit hyperactivity disorder, oppositional defiant disorder) as indicated on their treatment plan, and 3) receiving 1:1 aide support.
- Supervisors must be employed by a community behavior health agency and supervise a participating aide. The investigators will recruit supervisors in dyads and not triads (i.e., no supervisors with two [or more] aides) to ensure there are 30 supervisor-aide dyads in total).
Exclusion Criteria
- Aides who participated in the pilot trial of the Footsteps will be excluded from participating to recruit a sample naïve to Footsteps and the control app.
Recruiting US locations
University of Pennsylvania
Philadelphia, PA 19104
Site contact: Heather J Nuske, PhD · 215-746-6041 · heather.nuske@pennmedicine.upenn.edu
Study contacts (from the official record)
- Heather J Nuske, PhD · (215) 746-6041 · heather.nuske@pennmedicine.upenn.edu
- David Mandell, Sc.D. · david.mandell@pennmedicine.upenn.edu
Similar studies in Pennsylvania
All mental health studies in Pennsylvania →- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Philadelphia, PA + 50 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Pupillometry in Identifying Risk of Postoperative Opioid-induced Respiratory Depression in Children Undergoing Tonsillectomy
NeurOptics Inc
- Location
- Pittsburgh, PA
- Eligibility basics
- Ages 3–17
- RecruitingPhase 3
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
Definium Therapeutics US, Inc.
- Location
- Philadelphia, PA + 22 other US sites
- Eligibility basics
- Ages 18–74
- RecruitingPhase 3
A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
Neurocrine Biosciences
- Location
- Philadelphia, PA + 19 other US sites
- Eligibility basics
- Ages 18+